When to reinvite initially ineligible populations for targeted lung cancer screening?

IF 3.6 3区 医学 Q1 RESPIRATORY SYSTEM
Patrick Goodley, Philip A J Crosbie, Matthew Sperrin, Zoe Merchant, Richard Booton, Haval Balata
{"title":"When to reinvite initially ineligible populations for targeted lung cancer screening?","authors":"Patrick Goodley, Philip A J Crosbie, Matthew Sperrin, Zoe Merchant, Richard Booton, Haval Balata","doi":"10.1136/bmjresp-2023-002193","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Targeted low-dose CT lung cancer screening reduces lung cancer mortality. England's Targeted Lung Health Check programme uses risk prediction tools to determine eligibility for biennial screening among people with a smoking history aged 55-74. Some participants initially ineligible for lung cancer screening will later become eligible with increasing age and ongoing tobacco exposure. It is, therefore, important to understand how many people could qualify for reinvitation, and after how long, to inform implementation of services.</p><p><strong>Methods: </strong>We prospectively predicted future risk (using Prostate, Lung, Colorectal and Ovarian trial's risk model (PLCO<sub>m2012</sub>) and Liverpool Lung Project version 2 (LLP<sub>v2</sub>) risk models) and time-to-eligibility of 5345 participants to estimate how many would become eligible through the course of a Lung Health Check screening programme for 55-74 years.</p><p><strong>Results: </strong>Approximately a quarter eventually become eligible, with those with the lowest baseline risks unlikely to ever become eligible. Time-to-eligibility is shorter for participants with higher baseline risk, increasing age and ongoing smoking status. At a PLCO<sub>m2012</sub> threshold ≥1.51%, 68% of those who continue to smoke become eligible compared with 18% of those who have quit.</p><p><strong>Discussion: </strong>Predicting which participants may become eligible, and when, during a screening programme can help inform reinvitation strategies and service planning. Those with risk scores closer to the eligibility threshold, particularly people who continue to smoke, will reach eligibility in subsequent rounds while those at the lowest risk may be discharged from the programme from the outset.</p>","PeriodicalId":9048,"journal":{"name":"BMJ Open Respiratory Research","volume":"11 1","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11097831/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Respiratory Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjresp-2023-002193","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Targeted low-dose CT lung cancer screening reduces lung cancer mortality. England's Targeted Lung Health Check programme uses risk prediction tools to determine eligibility for biennial screening among people with a smoking history aged 55-74. Some participants initially ineligible for lung cancer screening will later become eligible with increasing age and ongoing tobacco exposure. It is, therefore, important to understand how many people could qualify for reinvitation, and after how long, to inform implementation of services.

Methods: We prospectively predicted future risk (using Prostate, Lung, Colorectal and Ovarian trial's risk model (PLCOm2012) and Liverpool Lung Project version 2 (LLPv2) risk models) and time-to-eligibility of 5345 participants to estimate how many would become eligible through the course of a Lung Health Check screening programme for 55-74 years.

Results: Approximately a quarter eventually become eligible, with those with the lowest baseline risks unlikely to ever become eligible. Time-to-eligibility is shorter for participants with higher baseline risk, increasing age and ongoing smoking status. At a PLCOm2012 threshold ≥1.51%, 68% of those who continue to smoke become eligible compared with 18% of those who have quit.

Discussion: Predicting which participants may become eligible, and when, during a screening programme can help inform reinvitation strategies and service planning. Those with risk scores closer to the eligibility threshold, particularly people who continue to smoke, will reach eligibility in subsequent rounds while those at the lowest risk may be discharged from the programme from the outset.

何时重新邀请最初不符合条件的人群接受肺癌目标筛查?
简介:有针对性的低剂量 CT 肺癌筛查可降低肺癌死亡率:有针对性的低剂量 CT 肺癌筛查可降低肺癌死亡率。英格兰的 "目标肺健康检查 "计划使用风险预测工具来确定 55-74 岁有吸烟史的人是否有资格接受两年一次的筛查。一些最初不符合肺癌筛查条件的参与者后来会随着年龄的增长和持续的烟草暴露而符合条件。因此,了解有多少人有资格重新接受筛查以及重新接受筛查的时间有多长非常重要,这将为筛查服务的实施提供依据:方法:我们对 5345 名参与者的未来风险(使用前列腺、肺、结肠直肠和卵巢试验的风险模型 (PLCOm2012) 和利物浦肺项目第 2 版 (LLPv2) 风险模型)和符合条件的时间进行了前瞻性预测,以估计有多少人将在 55-74 岁期间通过肺健康检查筛查项目符合条件:结果:大约四分之一的人最终符合条件,而基线风险最低的人则不太可能符合条件。基线风险越高、年龄越大和持续吸烟的参与者符合条件的时间越短。当PLCOm2012阈值≥1.51%时,68%的继续吸烟者符合条件,而18%的已戒烟者不符合条件:讨论:在筛查项目中预测哪些参与者可能符合条件以及何时符合条件,有助于为再邀请策略和服务规划提供依据。那些风险分数接近合格阈值的人,尤其是继续吸烟的人,将在随后的几轮筛查中达到合格标准,而那些风险最低的人可能从一开始就被排除在筛查计划之外。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Open Respiratory Research
BMJ Open Respiratory Research RESPIRATORY SYSTEM-
CiteScore
6.60
自引率
2.40%
发文量
95
审稿时长
12 weeks
期刊介绍: BMJ Open Respiratory Research is a peer-reviewed, open access journal publishing respiratory and critical care medicine. It is the sister journal to Thorax and co-owned by the British Thoracic Society and BMJ. The journal focuses on robustness of methodology and scientific rigour with less emphasis on novelty or perceived impact. BMJ Open Respiratory Research operates a rapid review process, with continuous publication online, ensuring timely, up-to-date research is available worldwide. The journal publishes review articles and all research study types: Basic science including laboratory based experiments and animal models, Pilot studies or proof of concept, Observational studies, Study protocols, Registries, Clinical trials from phase I to multicentre randomised clinical trials, Systematic reviews and meta-analyses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信